|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 221.85 USD | +2.25% |
|
-0.39% | -3.11% |
| 06-13 | Natera, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:20 AM | |
| 06-12 | Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -26.99 | -25.71 | -19.67 | -8.96 | -9.54 | |||||
Return on Total Capital | -32.19 | -30.71 | -23.64 | -10.73 | -11.71 | |||||
Return On Equity % | -82.79 | -80.62 | -59.11 | -19.42 | -14.32 | |||||
Return on Common Equity | -82.79 | -80.62 | -59.11 | -19.42 | -14.32 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.09 | 44.37 | 45.52 | 60.3 | 64.75 | |||||
SG&A Margin | 81.7 | 71.76 | 57.11 | 49.58 | 51.05 | |||||
EBITDA Margin % | -73.23 | -63.95 | -39.22 | -11.48 | -11.77 | |||||
EBITA Margin % | -74.85 | -65.96 | -41.22 | -13.1 | -13.36 | |||||
EBIT Margin % | -74.85 | -65.96 | -41.22 | -13.1 | -13.44 | |||||
Income From Continuing Operations Margin % | -75.42 | -66.79 | -40.16 | -11.22 | -9.03 | |||||
Net Income Margin % | -75.42 | -66.79 | -40.16 | -11.22 | -9.03 | |||||
Net Avail. For Common Margin % | -75.42 | -66.79 | -40.16 | -11.22 | -9.03 | |||||
Normalized Net Income Margin | -47.08 | -41.6 | -25.09 | -6.99 | -7.27 | |||||
Levered Free Cash Flow Margin | -40.24 | -36.16 | -16.76 | 5.62 | 6.11 | |||||
Unlevered Free Cash Flow Margin | -39.61 | -35.61 | -16.15 | 5.96 | 6.23 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.58 | 0.62 | 0.76 | 1.09 | 1.14 | |||||
Fixed Assets Turnover | 7.14 | 5.72 | 6.52 | 8.16 | 7.71 | |||||
Receivables Turnover (Average Receivables) | 6.23 | 4.48 | 4.14 | 5.73 | 7.55 | |||||
Inventory Turnover (Average Inventory) | 13.57 | 14.64 | 15.49 | 15.76 | 14.36 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.99 | 3.9 | 4.1 | 4 | 3.39 | |||||
Quick Ratio | 4.73 | 3.68 | 3.77 | 3.73 | 3.11 | |||||
Operating Cash Flow to Current Liabilities | -1.53 | -1.39 | -0.8 | 0.39 | 0.49 | |||||
Days Sales Outstanding (Average Receivables) | 58.54 | 81.54 | 88.11 | 63.89 | 48.33 | |||||
Days Outstanding Inventory (Average Inventory) | 26.9 | 24.93 | 23.57 | 23.22 | 25.41 | |||||
Average Days Payable Outstanding | 23.46 | 29.62 | 21.66 | 18.64 | 19.27 | |||||
Cash Conversion Cycle (Average Days) | 61.98 | 76.84 | 90.01 | 68.47 | 54.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 60.8 | 63.23 | 57.75 | 15.65 | 12.52 | |||||
Total Debt / Total Capital | 37.81 | 38.74 | 36.61 | 13.53 | 11.13 | |||||
LT Debt/Equity | 52.26 | 50.76 | 45.73 | 8.08 | 6.92 | |||||
Long-Term Debt / Total Capital | 32.5 | 31.1 | 28.99 | 6.99 | 6.15 | |||||
Total Liabilities / Total Assets | 47.16 | 49.39 | 46.91 | 28.02 | 28.6 | |||||
EBIT / Interest Expense | -56.37 | -58.06 | -35.31 | -20.8 | -76.16 | |||||
EBITDA / Interest Expense | -53.84 | -54.81 | -32.45 | -16.8 | -61.74 | |||||
(EBITDA - Capex) / Interest Expense | -59.81 | -59.92 | -35.55 | -23.02 | -87.84 | |||||
Total Debt / EBITDA | -0.89 | -0.87 | -1.08 | -1.04 | -0.85 | |||||
Net Debt / EBITDA | 1.16 | 0.89 | 1.07 | 4.35 | 3.43 | |||||
Total Debt / (EBITDA - Capex) | -0.8 | -0.8 | -0.98 | -0.76 | -0.6 | |||||
Net Debt / (EBITDA - Capex) | 1.04 | 0.81 | 0.97 | 3.18 | 2.41 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 59.97 | 31.13 | 31.99 | 56.75 | 35.9 | |||||
Gross Profit, 1 Yr. Growth % | 63.87 | 18.53 | 35.38 | 107.65 | 45.94 | |||||
EBITDA, 1 Yr. Growth % | 119.5 | 14.52 | -19.06 | -54.11 | 39.32 | |||||
EBITA, 1 Yr. Growth % | 116.47 | 15.56 | -17.52 | -50.19 | 38.64 | |||||
EBIT, 1 Yr. Growth % | 116.47 | 15.56 | -17.52 | -50.19 | 39.41 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 105.32 | 16.13 | -20.63 | -56.2 | 9.31 | |||||
Net Income, 1 Yr. Growth % | 105.32 | 16.13 | -20.63 | -56.2 | 9.31 | |||||
Normalized Net Income, 1 Yr. Growth % | 110.42 | 15.87 | -20.54 | -56.34 | 41.3 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 83.45 | 6.87 | -32.08 | -59.62 | -0.28 | |||||
Accounts Receivable, 1 Yr. Growth % | 55.38 | 100.19 | 13.87 | 12.89 | -5.61 | |||||
Inventory, 1 Yr. Growth % | 34.34 | 31.58 | 15.12 | 9.78 | 52.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 130.42 | 34.44 | 2.08 | 47.96 | 40.91 | |||||
Total Assets, 1 Yr. Growth % | 32.65 | 12.78 | 3.39 | 15.19 | 44.41 | |||||
Tangible Book Value, 1 Yr. Growth % | 34.36 | 8.41 | 8.44 | 56.2 | 1.11 | |||||
Common Equity, 1 Yr. Growth % | 34.36 | 8.03 | 8.44 | 56.2 | 43.25 | |||||
Cash From Operations, 1 Yr. Growth % | 83.68 | 28.72 | -42.77 | -154.93 | 58.7 | |||||
Capital Expenditures, 1 Yr. Growth % | 152.95 | -3.81 | -17.82 | 69.45 | 59.87 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 92.44 | 17.85 | -38.7 | -152.62 | 49.78 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 103.87 | 17.89 | -40.01 | -157.86 | 43.8 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 43.84 | 44.84 | 31.56 | 43.83 | 45.95 | |||||
Gross Profit, 2 Yr. CAGR % | 55.58 | 39.37 | 26.68 | 67.66 | 74.08 | |||||
EBITDA, 2 Yr. CAGR % | 93.46 | 58.55 | -3.72 | -39.06 | -20.04 | |||||
EBITA, 2 Yr. CAGR % | 90.58 | 58.16 | -2.37 | -35.9 | -16.9 | |||||
EBIT, 2 Yr. CAGR % | 90.58 | 58.16 | -2.37 | -35.9 | -16.66 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 94.4 | 54.42 | -3.99 | -41.04 | -30.81 | |||||
Net Income, 2 Yr. CAGR % | 94.4 | 54.42 | -3.99 | -41.04 | -30.81 | |||||
Normalized Net Income, 2 Yr. CAGR % | 86.5 | 56.15 | -3.96 | -41.05 | -21.45 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 70.38 | 40.1 | -14.8 | -47.63 | -36.54 | |||||
Accounts Receivable, 2 Yr. CAGR % | 51.27 | 76.37 | 50.99 | 13.38 | 3.22 | |||||
Inventory, 2 Yr. CAGR % | 47.35 | 32.95 | 23.07 | 12.42 | 29.58 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 63.34 | 76 | 17.15 | 22.9 | 44.39 | |||||
Total Assets, 2 Yr. CAGR % | 45.68 | 22.31 | 7.98 | 9.13 | 28.98 | |||||
Tangible Book Value, 2 Yr. CAGR % | 53.16 | 20.69 | 8.43 | 30.15 | 25.09 | |||||
Common Equity, 2 Yr. CAGR % | 53.1 | 20.48 | 8.23 | 30.15 | 49.58 | |||||
Cash From Operations, 2 Yr. CAGR % | 129.87 | 53.76 | -14.17 | -43.93 | -6.63 | |||||
Capital Expenditures, 2 Yr. CAGR % | 215.93 | 55.98 | -11.09 | 18.01 | 64.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 421.56 | 50.59 | -15.04 | -43.21 | -12.03 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 300.06 | 55.03 | -15.93 | -41.08 | -9.58 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 34.4 | 39.47 | 40.42 | 39.47 | 41.14 | |||||
Gross Profit, 3 Yr. CAGR % | 49.66 | 42.1 | 38.03 | 49.36 | 60.08 | |||||
EBITDA, 3 Yr. CAGR % | 61.65 | 62.44 | 26.71 | -24.79 | -19.72 | |||||
EBITA, 3 Yr. CAGR % | 59.85 | 61.31 | 27.31 | -21.99 | -17.1 | |||||
EBIT, 3 Yr. CAGR % | 59.85 | 61.31 | 27.31 | -21.99 | -16.95 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 54.4 | 63.72 | 23.69 | -26.09 | -27.57 | |||||
Net Income, 3 Yr. CAGR % | 54.4 | 63.72 | 23.69 | -26.09 | -27.57 | |||||
Normalized Net Income, 3 Yr. CAGR % | 54.48 | 59.14 | 24.73 | -26.15 | -21.1 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 32.89 | 45.84 | 10.06 | -33.57 | -35.09 | |||||
Accounts Receivable, 3 Yr. CAGR % | 25.19 | 66.08 | 52.44 | 37.04 | 6.66 | |||||
Inventory, 3 Yr. CAGR % | 25.44 | 41.89 | 26.72 | 18.47 | 24.57 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 75.44 | 53.08 | 46.78 | 26.63 | 28.63 | |||||
Total Assets, 3 Yr. CAGR % | 66.44 | 33.76 | 15.65 | 10.33 | 19.81 | |||||
Tangible Book Value, 3 Yr. CAGR % | 177.51 | 36.5 | 16.46 | 22.46 | 19.28 | |||||
Common Equity, 3 Yr. CAGR % | 172.85 | 36.3 | 16.32 | 22.31 | 34.38 | |||||
Cash From Operations, 3 Yr. CAGR % | 68.09 | 89.47 | 10.61 | -26.03 | -20.69 | |||||
Capital Expenditures, 3 Yr. CAGR % | 133.8 | 112.54 | 25.98 | 10.23 | 30.58 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 48.74 | 217.67 | 11.52 | -27.58 | -21.89 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 52.15 | 166.22 | 12.88 | -25.78 | -21.02 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 24.1 | 31.37 | 33.26 | 41.2 | 42.61 | |||||
Gross Profit, 5 Yr. CAGR % | 31.25 | 39.05 | 40.01 | 51.82 | 51.45 | |||||
EBITDA, 5 Yr. CAGR % | 37.45 | 32.34 | 31.39 | 9.75 | 5.4 | |||||
EBITA, 5 Yr. CAGR % | 36.46 | 31.94 | 31.24 | 11.51 | 7.34 | |||||
EBIT, 5 Yr. CAGR % | 36.46 | 31.94 | 31.24 | 11.51 | 7.46 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 36.29 | 31.82 | 27.68 | 8.81 | -1.95 | |||||
Net Income, 5 Yr. CAGR % | 36.29 | 31.82 | 27.68 | 8.81 | -1.95 | |||||
Normalized Net Income, 5 Yr. CAGR % | 36.82 | 31.83 | 27.73 | 6.97 | 3.67 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 21.72 | 16.55 | 11.24 | -3.18 | -11.7 | |||||
Accounts Receivable, 5 Yr. CAGR % | 55.57 | 40.85 | 34.93 | 42.56 | 30.43 | |||||
Inventory, 5 Yr. CAGR % | 33.22 | 31.52 | 24.49 | 29.27 | 27.86 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 31.58 | 43.43 | 49.27 | 40.2 | 45.82 | |||||
Total Assets, 5 Yr. CAGR % | 42.47 | 45.4 | 39.99 | 23.3 | 20.8 | |||||
Tangible Book Value, 5 Yr. CAGR % | 43.99 | 98.64 | 90.55 | 33.92 | 19.84 | |||||
Common Equity, 5 Yr. CAGR % | 43.74 | 94.4 | 88.5 | 33.81 | 28.63 | |||||
Cash From Operations, 5 Yr. CAGR % | 35.26 | 34.56 | 28.47 | 16.42 | 3.36 | |||||
Capital Expenditures, 5 Yr. CAGR % | 16.47 | 37.04 | 58.81 | 67.97 | 40.2 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 29.94 | 23.44 | 18.85 | 59.48 | 1.52 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 29.66 | 23.66 | 19.97 | 45.56 | 3.39 |
- Stock Market
- Stocks
- NTRA Stock
- Financials Natera, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















